 | Scott Eric Kasner, Philip B. Gorelick - 2004 - 446 páginas
...pressure reduction: a metaanalysis. Lancet 2001;358:1305-1315. 47. Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive...as first-line agents: a network meta-analysis. JAMA 2003;289:2534-2544. 48. Dahlof B. Devereux RB. Kjeldsen SE, et al. Cardiovascular morbidity and mortality... | |
 | Institute of Medicine, Food and Nutrition Board, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Panel on Dietary Reference Intakes for Electrolytes and Water - 2005 - 648 páginas
...Chicago: Year Book Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS. 2003. Health outcomes associated with various antihypertensive...used as first-line agents. A network meta-analysis. J Am Med Assoc 289:25342544. Rastenyte D, Tuomilehto J, Moltchanov V, Lindtrson J, Pietinen P, Nissinen... | |
 | Gerald van Belle, Lloyd D. Fisher, Patrick J. Heagerty, Thomas Lumley - 2004 - 896 páginas
...Psaty, B., Lumley, T., Furberg, C., Schellenbaum, G., Pahor, M., Alderman, MH, and Weiss, NS [2003]. Health outcomes associated with various anti-hypertensive...used as first-line agents: a network meta-analysis. Journal of the American Medical Association, 289: 2532-2542. Ramsay, TO, Burnett, RT, and Krewski,... | |
 | Nortin M. Hadler - 2004 - 340 páginas
...24 August 1998. In: The Cochrane Library. Oxford: Update software. Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents. JAMA 2003; 289: 2534-44. Psaty BM, Weiss NS, Furberg CD, et al. Surrogate end points, health outcomes,... | |
 | Joseph S. Alpert - 2005 - 528 páginas
...the soft science of the secondary end point. Ann Intern Med 2003, 139:777-780. 32. Psaty B, Lumley T, et al.: Health outcomes associated with various antihypertensive...as first-line agents, a network meta-analysis. JAMA 2003, 289:2534-2544. 33. Wing L, Reid C, eta/.: A Comparison of outcomes with angiotensin-converting-enzyme... | |
 | Clive Rosendorff - 2007 - 888 páginas
...or calcium channel blocker vs diuretic. JAMA 2002;288:2981-2997. 30. Psaty BM, Lumley T, Furber CD, et al. Health outcomes associated with various antihypertensive...as first-line agents: a network meta-analysis. JAMA 2003;289:2534-2544. 31. Brown NJ. Eplerenone: cardiovascular protection. Circulation 2003;107:2512-2518.... | |
 | Chi-Jen Lee, Lucia H. Lee, Christopher L. Wu, Benjamin R. Lee, Mei-Ling Chen - 2005 - 520 páginas
...Evaluation, and Treatment of High Blood Pressure, The JNC 7 Report, JAMA, 289, 2560, 2003. 4. Psaty. BM et al.. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network analysis, JAMA, 289, 2534, 2003. 5. Pitt, B. et al.. The effect of spironolactone on morbidity and... | |
 | L. Michael Prisant - 2007 - 532 páginas
...stroke/transient ischaemic attack. Cerebrovasc Dis 2003;16(suppl 1):14-19. 15. Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analy sis. JAMA 2003;289:2534-2544. 16. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke,... | |
 | Lionel H. Opie - 2005 - 460 páginas
...W, et al. Effects of oral diuretics on raised arterial pressure. Lancet 1963:2:966-969. 2. Psaty BM, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents. IAMA 2003:289:2534-2544. 3. BP Trialists. Effects of different blood-pressure lowering regimens on... | |
 | Peter Schauder - 2006 - 662 páginas
...Inhibitors and diuretics for hypertension in the elderly. N Engl J Med (2003), 348, 583-592 [ 1 9] Psaty BM et al., Health outcomes associated with various antihypertensive...as first-line agents: a network metaanalysis. JAMA (2003), 289, 2534-2544 [20] Law MR et al., Value of Iow dose combination treatment with blood pressure... | |
| |
Psaty BM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: A network meta-analysis. 
